| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |